Clinical Trials Sponsored by Vantia Ltd

Total 19202 results

Vantia Ltd

Completed

Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC)

Nocturia

United States
Vantia Ltd

Completed

A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval

Healthy

Germany
Vantia Ltd

Completed

Efficacy Study of VA106483 in Males With Nocturia.

Nocturia

United States
Vantia Ltd

Completed

VA106483 Dose Response in Females

Nocturia

United States
Vantia Ltd

Completed

VA106483 and Alpha Blocker Interaction Study in Elderly Males

Nocturia

United Kingdom
Vantia Ltd

Completed

VA106483 Dose Response Study in Elderly Males

Nocturia

United States
Vantia Ltd

Completed

Dose Range Finding Study of Fedovapagon in Men With Nocturia

Nocturia

United States
Vantia Ltd

Completed

VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept

Primary Dysmenorrhea

United States, United Kingdom
Vantia Ltd

Completed

Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon

Nocturia

Germany
Vantia Ltd

Completed

Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)

Nocturia | Benign Prostatic Hypertrophy (BPH)

Germany
Vantia Ltd

Completed

VA111913 TS: First in Human Study

Dysmenorrhea

United Kingdom
Vantia Ltd
Veeda Clinical Research

Completed

Efficacy and Safety of VA106483 in Elderly Males

Nocturia

United Kingdom
Entia Ltd

Not yet recruiting

HOme USability Evaluation (HOUSE)

Cancer
Entia Ltd

Not yet recruiting

Capillary-Venous Paired Data Collection (CaVeP-DC)

Oncology
Entia Ltd

Completed

Entia Liberty: Home Study

Cancer

United Kingdom
Entia Ltd

Completed

Entia Liberty: Usability Validation

Cancer

United Kingdom
Entia Ltd

Enrolling by invitation

Blood Testing at Entia

Healthy

United Kingdom
Entia Ltd

Completed

Project Affinity: Excess Cancer Blood Testing

Cancer

United Kingdom
Vatic Ltd.

Unknown

Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen

Covid19
Entia Ltd

Completed

Project Aura: Home Trial of a Home-based Monitoring Service

Chronic Kidney Diseases

United Kingdom
Entia Ltd

Completed

Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia

Anemia | Iron Deficiency Anemia

United Kingdom
Entia Ltd

Completed

Entia Liberty: Accuracy and Precision

Cancer

United Kingdom
Entia Ltd

Not yet recruiting

Capillary-Venous Paired Collection (CaVe)

Cancer
Entia Ltd

Completed

PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

Cancer

United Kingdom
Entia Ltd

Withdrawn

Project Aura: Co-design of a Home-based Monitoring Service

Anemia of Chronic Kidney Disease

United Kingdom
Yantai YenePharma Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet

Intracranial Hemorrhages | Stroke, Acute

United States
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001

COVID-19
Juvantia Pharma Ltd
Santhera Pharmaceuticals

Completed

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease (Fjord)

Parkinson's Disease

United States, India
Xijing Hospital
Yantai Medgenn Ltd.

Unknown

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

Lung Neoplasms

China
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

The Phase Ⅱ/Ⅲ Trial of LYB001

COVID-19
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001

COVID-19
Taewoong Medical Co., Ltd.
Avania

Active, not recruiting

PULSTA Transcatheter Pulmonary Valve Pre-Approval Study

Heart Diseases | Tetralogy of Fallot | Pulmonary Valve Stenosis | Pulmonary Valve Regurgitation

Germany, Spain, Korea, Republic of, Italy, Netherlands, Turkey
Juvantia Pharma Ltd
Santhera Pharmaceuticals

Unknown

Fipamezole in Neurogenic Orthostatic Hypotension (Foehn)

Parkinson's Disease | Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension (NOH)

France, Portugal
Yantai LNC Biotechnology Singapore PTE. LTD.

Not yet recruiting

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Metastatic Castration-resistant Prostate Cancer, mCRPC
Cardialen, Inc.
Iqvia Pty Ltd; Avania

Terminated

MultiPulse Therapy (MPT) for AF

Atrial Fibrillation | Atrial Fibrillation, Persistent | Atrial Fibrillation, Paroxysmal

Australia
Yantai LNC Biotechnology Singapore PTE. LTD.

Recruiting

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Solid Tumor, Unspecified, Adult

Singapore
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Resvent Holding USA LTD
Avania; Resvent Medical Technology Co., Ltd.

Not yet recruiting

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

COVID-19

China
Ceryx Medical Australia
Avania

Not yet recruiting

Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF (RSA-PACE)

Heart Failure With Reduced Ejection Fraction

New Zealand
Entia Ltd
The Christie NHS Foundation Trust

Completed

Affinity: Hospital Trial

Cancer

United Kingdom
Yantai Yuhuangding Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer

Breast Cancer

China
A-Mansia Biotech S.A.
Vedic Lifesciences Pvt. Ltd.

Not yet recruiting

Study to Assess Effects of Pasteurized Akkermansia Muciniphila vs Placebo in Participants With Diarrhea-predominant IBS (PAM-DIGEST)

Diarrhea-Predominant Irritable Bowel Syndrome

India
Entia Ltd
The Christie NHS Foundation Trust

Completed

Entia Liberty: Capillary Validation

Cancer

United Kingdom
Antia Therapeutics AG

Unknown

Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions (Ideale)

Arterial Embolization
Antria

Unknown

Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound

Chronic Wounds

United States

Clinical Trials Sponsored by Vantia Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations